TAG:
laboratory business
Catfight in New York Over Lab Supplies Law
By Robert Michel | From the Volume IX No. 5 – April 1, 2002 Issue
CEO SUMMARY: All labs serving physicians’ offices worry about the delicate balance between complying with laws governing inducement and protecting clients against competing labs who interpret those same laws more liberally. Recent events in New York state graphically demonstrate the com…
“March 11, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
Down in Orlando, Florida, Cognescenti Health Institute, now opening a newly-constructed clinical laboratory, has selected LabDat, Inc. to provide browser-based lab test ordering and results reporting. In response to the anticipated changes caused by genomic and prot…
In the Aftermath of Terror: Labs Deal With New Issues
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
SELDOM DO I WRITE IN FIRST PERSON to our clients and regular readers. Yet the events of the past few weeks—and the uncertain path our nation is about to take into the future—impel me to share some insights and thoughts. Like most of you, I watched the television coverage of these tragic events a…
Investors Pump $107 Million Into Unilab’s Stock Offering
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
HERE’S ENCOURAGING NEWS for owners of independent regional laboratories: investors on Wall Street continue to like the laboratory business…a lot! Latest confirmation of this fact came on June 6, when Unilab Corporation of Tarzana, California funded its initial public offering (I…
Lab Owners Selling Stock To Harvest Big Profits
By Robert Michel | From the Volume VIII No. 7 – May 21, 2001 Issue
CEO SUMMARY: Three huge stock sales involving the nation’s largest laboratories have been announced in recent weeks. If these stock sales are enthusiastically received by Wall Street investors, independent regional lab owners may benefit because of higher valuations for clinical laborat…
Summary and Overview of Lab Industry
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
If there is any common theme to the different chapters of this White Paper on the laboratory industry, it is probably this: in the next couple of years, clinical laboratories will continue to have one foot in the past and one foot in the future. Simply put, lab administrators will continue to manag…
IPO Is Major Strategy For American Med Labs
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial publi…
Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Probably no one is better positioned to identify the evolution of laboratory information services than Bruce Friedman, M.D., Professor of Pathology at the University of Michigan Medical School in Ann Arbor. For almost 20 years, he has hosted the pre-eminent meeting in laborat…
Neurology is Test Focus For Athena Diagnostics
CEO SUMMARY: There are few examples of laboratory companies focused on a single medical specialty,a business model that is expected to become more common in coming years. One such company is Athena Diagnostics. For 12 years, this company has concentrated on providing diagnostic testing fo…
Spectrum Labs Selects Nate Headley To Be CEO
By Robert Michel | From the Volume VII No. 6 – April 17, 2000 Issue
CEO SUMMARY: Spectrum Laboratory Network, a joint venture among several large hospitals, recently selected Nate Headley to be its new Chief Executive Officer. Since its launch in 1997, Spectrum has performed below the expectations of its hospital owners. It was to enhance laboratory servi…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized